Scarica l'app Stockscreener
3.25
10.22%
-0.37
Dopo l'orario di chiusura:
3.80
0.55
+16.92%
Precedente Chiudi:
$3.62
Aprire:
$3.65
Volume 24 ore:
274.35K
Relative Volume:
1.45
Capitalizzazione di mercato:
$2.60M
Reddito:
-
Utile/perdita netta:
$-4.21M
Rapporto P/E:
-59.31
EPS:
-0.0548
Flusso di cassa netto:
-
1 W Prestazione:
-6.61%
1M Prestazione:
-61.31%
6M Prestazione:
-97.97%
1 anno Prestazione:
-99.93%
Intervallo 1D:
$3.21
$3.75
Intervallo di 1 settimana:
$3.21
$4.39
Portata 52W:
$3.21
$4,680.00
Conduit Pharmaceuticals Inc Stock (CDT) Company Profile
Nome
Conduit Pharmaceuticals Inc
Settore
Industria
Telefono
(646) 491 9132
Indirizzo
4851 TAMIAMI TRAIL NORTH, NAPLES
Confronta CDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDT
Conduit Pharmaceuticals Inc
|
3.25 | 2.78M | 0 | -4.21M | 0 | -0.0548 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Conduit Pharmaceuticals Inc Borsa (CDT) Ultime notizie
CDT stock plunges to 52-week low, hitting $3.21 amid steep decline - Investing.com UK
Conduit Pharmaceuticals regains Nasdaq compliance - MSN
Conduit Pharmaceuticals receives approval for Nasdaq listing - MSN
Conduit Pharmaceuticals approved to transfer listing to Nasdaq Capital Market - TipRanks
Conduit Pharmaceuticals moves to Nasdaq Capital Market By Investing.com - Investing.com India
Conduit Pharma Gains Nasdaq Capital Market Approval, Transfer Effective May 23 - Nasdaq
Conduit Pharmaceuticals moves to Nasdaq Capital Market - Investing.com Australia
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market - The Manila Times
Biotech Rising Star Conduit Pharmaceuticals Gets Green Light for Nasdaq Capital Market Transfer - Stock Titan
Conduit Pharmaceuticals meets Nasdaq listing standards By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals meets Nasdaq listing standards - Investing.com Australia
Conduit Pharmaceuticals Regains Compliance With Nasdaq's Bid Price, Equity Requirements - marketscreener.com
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance - The Manila Times
Conduit Pharmaceuticals Inc. Regains Compliance with Nasdaq Listing Requirements - Nasdaq
Conduit Pharmaceuticals Secures Future on Nasdaq: Clears Both Bid Price and Equity Hurdles - Stock Titan
Upcoming Stock Splits This Week (May 19 to May 23) – Stay Invested - The Globe and Mail
Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic - Asianet Newsable
Conduit Pharmaceuticals approves reverse stock split By Investing.com - Investing.com South Africa
Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic By Stocktwits - Investing.com India
Conduit Pharmaceuticals Announces Reverse Stock Split - TipRanks
Barclays PLC Buys 54,523 Shares of Conduit Pharmaceuticals Inc. (NASDAQ:CDT) - Defense World
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - The Manila Times
Conduit Pharmaceuticals approves reverse stock split - Investing.com
Conduit Pharmaceuticals Inc. Announces 1-for-15 Reverse Stock Split Approval - Nasdaq
CONDUIT PHARMACEUTICALS INC. SEC 10-Q Report - TradingView
Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - The Manila Times
Conduit Pharmaceuticals Secures Korean Patent for AZD1656, Advancing Global Development Strategy for Autoimmune Disorders - Nasdaq
Conduit Pharmaceuticals Files New Patent For AZD5904 - marketscreener.com
In 2025, Will Conduit Pharmaceuticals Inc (NASDAQ: CDT) Be Bullish Or Bearish? - Stocksregister
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset - The Manila Times
Conduit Pharmaceuticals Approves Reverse Stock Split Amendments - TipRanks
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Shares Acquired by Geode Capital Management LLC - Defense World
Conduit Pharmaceuticals Inc (CDT)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Increases By 98.5% - Defense World
Keeping an Eye on Conduit Pharmaceuticals Inc (CDT) After Insider Trading Activity - knoxdaily.com
Conduit Pharmaceuticals Inc (CDT)’s Day in Review: Closing at 0.56, Up by 4.07 - DWinneX
Investor’s Delight: Conduit Pharmaceuticals Inc (CDT) Closes Weak at 0.65, Down -5.79 - DWinneX
Conduit Pharmaceuticals (NASDAQ:CDT) Stock Price Down 2.9% – Time to Sell? - Defense World
What Do Wall Street Analysts Think About Conduit Pharmaceuticals Inc (NASDAQ: CDT) Stock? - Stocksregister
Conduit Pharmaceuticals files to sell 2.1M shares of common stock for holders - MSN
Conduit Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
Are Conduit Pharmaceuticals Inc (CDT) shares a good deal now? - uspostnews.com
Market Resilience: Conduit Pharmaceuticals Inc (CDT) Finishes Weak at 0.62, Down -20.51 - DWinneX
CDT’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
CDTConduit Pharms Latest Stock News & Market Updates - Stock Titan
Conduit Pharmaceuticals Announces Leadership Changes - marketscreener.com
Conduit Pharmaceuticals Inc Azioni (CDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):